3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Multiple Myeloma
242
Neoplasms, Plasma Cell
50
Lymphoma
45
Lymphoma, Mantle-Cell
40
Precursor Cell Lymphoblastic Leukemia-Lymphoma
31
Lymphoma, Non-Hodgkin
30
Recurrence
29
Lymphoma, Follicular
24
Leukemia, Myeloid, Acute
24
Lymphoma, Large B-Cell, Diffuse
23
Waldenstrom Macroglobulinemia
22
Lymphoma, B-Cell, Marginal Zone
20
Leukemia
20
Immunoglobulin Light-chain Amyloidosis
18
Leukemia, Lymphocytic, Chronic, B-Cell
14
Myelodysplastic Syndromes
12
Carcinoma, Non-Small-Cell Lung
12
Neoplasms
11
Hodgkin Disease
11
Burkitt Lymphoma
10
Breast Neoplasms
10
Lymphoma, T-Cell, Peripheral
9
Lymphoma, Large-Cell, Anaplastic
9
Lymphoma, B-Cell
9
Lung Neoplasms
9
Immunoblastic Lymphadenopathy
9
Hematologic Neoplasms
9
Prostatic Neoplasms
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell
8
Interventions
fludarabine phosphate
3
Peripheral Blood Stem Cell Transplantation
3
Epoetin Alfa
3
Darbepoetin alfa
3
Cyclophosphamide
3
Curcumin
3
Whole-Body Irradiation
2
Tacrolimus
2
Mycophenolic Acid
2
Methylprednisolone
2
Filgrastim
2
Cyclosporine
2
Busulfan
2
Biopsy
2
Antilymphocyte Serum
2
pyroxamide
1
piperine
1
liposomal amphotericin B
1
isatuximab
1
ibrutinib
1
ferrous sulfate
1
ferric gluconate
1
aldesleukin
1
Urination
1
Topotecan
1
Tissue Banks
1
Therapeutics
1
Tetradecanoylphorbol Acetate
1
Surveys and Questionnaires
1
Sucrose
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Monoclonal Gammopathy of Undetermined Significance
×
Bortezomib
×
Clear all
NCT00006362
2011-08-03
PS-341 in Treating Patients With Advanced Cancer
Mayo Clinic
Phase 1
Completed